Table of Contents
- Why Illiquid Investments Create Different Arbitration Issues Than Publicly Traded Stocks
- What Makes An Investment “Illiquid”?
- Why Publicly Traded Stock Cases Often Look Simpler
- The First Big Difference: Valuation Is Often Contested
- The Second Big Difference: Liquidity Restrictions Become Central
- The Third Big Difference: Suitability And “Fit” Often Carry More Weight
- The Fourth Big Difference: Distributions Can Be Misunderstood
- The Fifth Big Difference: Due Diligence Becomes A Front-And-Center Issue
- The Sixth Big Difference: The Evidence Often Lives In The Sales Conversation
- The Seventh Big Difference: Damages Can Be Harder To Calculate
- Arbitration Procedure Can Matter More Than Investors Expect
- Why Illiquid Cases Often Involve Concentration Claims
- Why These Cases Often Turn On Older Records
- Public Stocks Usually Provide Faster Feedback; Illiquid Products Often Delay It
- Why Attorney Experience In Similar Matters Can Matter More Here
- The Bottom Line
Type
Great Grandchild
Status
Approved
Caption
Title (YouTube)
Caption X
Cover
OG Image
Alt Image Text
Flat vector illustration of illiquid investments arbitration versus publicly traded stocks, showing valuation review, limited liquidity, and document-heavy dispute analysis.
Images
Videos
Video Published (Blog)
Publish Date (Social)
Aug 21, 2027 16:00
Scheduled (Social)
Scheduled (Social)
Images Posted (Social)
Images Failed (Social)
Videos Posted (Social)
Videos Failed (Social)
Featured
Do not index
Videos Post IDs (Social)
Created time
Apr 16, 2026 12:30 AM
Sub-item
Authors
Images Post IDs (Social)
YT Post ID
YT Embedded
Images Delete (Social)
Videos Delete (Social)
Why Illiquid Investments Create Different Arbitration Issues Than Publicly Traded Stocks
When investors think about brokerage arbitration, they often picture familiar stock-market disputes: a bad recommendation, excessive trading, or a sharp market drop in a publicly traded stock. But claims involving illiquid investments—such as non-traded REITs, non-publicly traded BDCs, private placements, and similar alternative products—often develop very differently.
That difference matters. Illiquid-investment cases frequently involve disputes over valuation, liquidity limits, account fit, due diligence, concentration, and disclosure in ways that ordinary stock cases often do not. In general terms, that can make these arbitrations more document-heavy, more fact-specific, and more dependent on what was said at the point of sale.
If you’re trying to understand why these cases feel different, this post will walk through the key distinctions. You’ll also see why investors in these matters often look for attorneys with documented experience handling highly similar claims, especially where the investment’s actual market value may have been difficult to see in real time.
For a broader foundation on these products themselves, it may help to start with this overview of illiquid alternative products and the risks that often come with them.
Scroll to the bottom for every post in this series.
What Makes An Investment “Illiquid”?
An illiquid investment is generally one that cannot be sold quickly at a transparent market price. Publicly traded stocks usually trade on an exchange, with continuously updated pricing and a ready pool of buyers and sellers. By contrast, many alternative investments do not trade on a national exchange, and investors may have limited ways to exit at all.
The SEC’s investor materials on non-traded REITs explain that, unlike exchange-traded REIT shares, non-traded REIT shares are not listed for trading on major exchanges and investor exit is often tied to a later liquidity event or a limited repurchase program rather than a daily public market. Likewise, the SEC’s bulletin on non-publicly traded BDCs notes that investors cannot sell those shares on an exchange and generally have fewer options to liquidate the position (Investor.gov on non-traded REITs; Investor.gov on non-publicly traded BDCs).
That basic structural feature changes a lot about a later dispute. In a public-stock arbitration, the parties can usually point to a market chart. In an illiquid-investment arbitration, the harder questions often include:
- What was the investment really worth at the time?
- Could the investor realistically get out?
- Was the product appropriate for the investor’s time horizon and risk tolerance?
- Did the firm have a reasonable basis to offer it in the first place?
- Were the risks described in a balanced, understandable way?
Why Publicly Traded Stock Cases Often Look Simpler
Publicly traded stock cases are not always simple, but they often involve clearer pricing evidence. A stock’s historical market price can be pulled from exchange records. The date of purchase, date of sale, trading volume, and price movement are usually straightforward. That can narrow the dispute to familiar issues like suitability, concentration, unauthorized trading, margin use, or misrepresentations.
Illiquid cases often lack that same transparency. FINRA has long emphasized that firms recommending complex or non-conventional investments are expected to understand the product, conduct due diligence, perform a reasonable-basis analysis, evaluate customer-specific suitability, provide balanced risk disclosures, maintain controls, and train representatives appropriately (FINRA Notice to Members 03-71; FINRA Regulatory Notice 12-03; FINRA Regulatory Notice 08-82).
That is one reason these arbitrations often turn into a deeper examination of the sales process, not just the investment’s later performance.
The First Big Difference: Valuation Is Often Contested
In stock cases, valuation usually comes from the market. In illiquid-product cases, valuation may come from an estimated net asset value, sponsor methodology, appraisals, internal models, or periodic statement values that do not function like exchange prices.
FINRA’s account-statement rule for certain DPP and REIT securities addresses how estimated per-share values may appear on customer statements, reflecting the industry reality that these products often rely on estimated values rather than live market pricing (FINRA Rule 2231; FINRA Regulatory Notice 15-02). The SEC has also noted that because non-traded REIT shares lack a trading market, investors are often left to assess the relationship between offering price and actual value without the benefit of exchange trading, and when issuers disclose estimated share value, the basis for that estimate becomes important (SEC CF Disclosure Guidance: Topic No. 6).
Here’s what that often means in arbitration: the investor may say the account statements created a false impression of stability, while the brokerage firm may argue the statements contained proper disclosures and reflected approved valuation methods. The dispute can shift from “the stock dropped from $40 to $18” to “what was this investment actually worth, when did that become knowable, and what did the broker understand about that valuation process?”
That valuation issue alone can make illiquid cases very different from publicly traded stock claims.
The Second Big Difference: Liquidity Restrictions Become Central
Publicly traded stocks can usually be sold any trading day, subject to ordinary market conditions. Illiquid investments are different. A non-traded REIT or non-publicly traded BDC may involve limited repurchase programs, redemption constraints, holding-period expectations, or no practical secondary market at all (Investor.gov on non-traded REITs; Investor.gov on non-publicly traded BDCs).
That matters because an arbitration claim may not be about a dramatic chart decline. It may be about the investor discovering that the money was effectively locked up during retirement, illness, business stress, or a change in financial circumstances. In those cases, lawyers and arbitrators often spend more time on questions like:
- Was the investor told how difficult resale could be?
- Was the investment pitched as income-producing but low-risk?
- Did the customer’s age, liquidity needs, or income dependence make the recommendation a poor fit?
- Was too much of the account concentrated in products with limited exit options?
These are often less visible in ordinary stock disputes because liquidity is taken for granted in publicly traded securities.
The Third Big Difference: Suitability And “Fit” Often Carry More Weight
Alternative-investment arbitration claims frequently focus on whether the product fit the investor’s profile at the time of recommendation. FINRA’s guidance on complex and non-conventional products repeatedly stresses the importance of a reasonable-basis review and customer-specific suitability analysis before recommendation (FINRA Notice to Members 03-71; FINRA Regulatory Notice 12-03; FINRA Regulatory Notice 08-82).
In a public-stock case, a recommendation can still be unsuitable, but the analysis may center on volatility, sector risk, trading frequency, or concentration in a stock that had an observable market. In an illiquid case, suitability often expands to include:
- time horizon,
- access to emergency cash,
- tolerance for an uncertain exit,
- appetite for opaque valuation,
- understanding of distributions,
- dependence on principal preservation, and
- concentration across multiple alternative products that may all become hard to sell at the same time.
That is why investors often ask a separate question entirely: not just “Did this lose money?” but “Was this ever appropriate for my account in the first place?”
The Fourth Big Difference: Distributions Can Be Misunderstood
Illiquid alternative products are often sold with an emphasis on income or yield. But distributions can be more complicated than many investors realize. FINRA Rule 2231 requires specific account-statement disclosure in some situations when part of a distribution includes a return of capital rather than earnings (FINRA Rule 2231).
In arbitration, that can become a major issue. Some claims center on whether regular distributions caused the investor to believe the product was performing well, even if principal value was deteriorating or the distributions were not entirely sourced from operating profits. Publicly traded stock cases can involve dividend misunderstandings too, but the issue tends to be more pronounced in illiquid alternative-product disputes because those products are often marketed around income, stability, and reduced correlation to public markets.
The Fifth Big Difference: Due Diligence Becomes A Front-And-Center Issue
When a brokerage firm offers a public stock, there is usually a public market, a large amount of public information, and real-time price discovery. With illiquid alternatives, the firm’s own product review and due diligence process can become a much larger part of the case.
FINRA has repeatedly stated that firms offering complex or non-conventional investments are expected to understand the product before recommending it, including risks, features, and suitability concerns (FINRA Notice to Members 03-71; FINRA Regulatory Notice 08-82). In practice, that can lead to arbitration discovery fights over:
- product-approval files,
- due-diligence memoranda,
- internal risk ratings,
- compensation structures,
- sales training materials,
- concentration thresholds,
- exception reports, and
- supervisory reviews.
That is a different shape of case than a simpler publicly traded stock dispute where there may be less need to unpack the firm’s decision to make the product available at all.
The Sixth Big Difference: The Evidence Often Lives In The Sales Conversation
With exchange-traded stocks, the damage story can sometimes be shown through account statements, trade confirmations, and market charts. Illiquid-investment cases often turn more heavily on what was said and how it was framed at the time of sale.
Common allegations include that the investment was described as:
- conservative,
- bond-like,
- income-focused without material downside,
- appropriate for retirees,
- easy to exit,
- insulated from stock-market volatility, or
- a modest sleeve of an account that later became a much larger concentration.
Whether those statements were actually made, and whether written disclosures adequately balanced them, often becomes central. That is one reason witnesses, notes, emails, presentations, and subscription documents may carry unusual weight.
The Seventh Big Difference: Damages Can Be Harder To Calculate
Damages in publicly traded stock cases may still be disputed, but there is often a shared reference point: the market price. Illiquid cases can involve much more debate over the right methodology.
The parties may disagree over whether damages should be measured using:
- original purchase price,
- later estimated NAV,
- redemption value,
- secondary-market indications,
- a liquidation event,
- income received over time,
- tax effects, or
- an expert’s reconstruction of value.
Because the investment may not have a reliable day-to-day market price, damages analyses can become more expert-driven. That often increases complexity and cost.
Arbitration Procedure Can Matter More Than Investors Expect
FINRA remains the primary forum for many customer disputes involving brokerage recommendations. Its statistics show that customer arbitration filings continue at meaningful volume. Through December 2025, FINRA reported 1,643 customer cases served in 2025, compared with 1,594 in 2024, and overall turnaround time for customer-related arbitration matters remained measured in months rather than weeks (FINRA 2025 Dispute Resolution Statistics).
Procedure matters in illiquid cases because the proof can be document-intensive. FINRA also amended its rules for simplified customer arbitrations, clarifying when the Document Production Lists apply in paper cases and special proceedings for cases filed on or after March 3, 2025 (FINRA Regulatory Notice 24-16). In a case involving a thinly traded or non-traded product, access to account-opening documents, concentration records, communications, and product-review materials may carry unusual importance.
In other words, the arbitration process itself may affect how effectively an investor can present a claim involving an opaque product.
Why Illiquid Cases Often Involve Concentration Claims
Another pattern in alternative-investment arbitrations is overconcentration. A single non-traded REIT, BDC, or private placement may already be hard to value and hard to sell. When several such products are placed into the same account, the risks can compound.
That can create a different problem than concentration in a public stock. A concentrated stock position may be volatile, but it is still generally visible and tradable. A concentrated basket of illiquid alternatives may expose an investor to:
- multiple products with limited exits,
- overlapping sector or credit risk,
- valuation opacity across the account,
- high fees,
- uneven disclosure practices, and
- reduced flexibility if cash is later needed.
If you’re trying to spot those warning signs, it may help to read more about how investors often evaluate whether an alternative product really fit the account, especially where liquidity needs and concentration were not fully explored.
Why These Cases Often Turn On Older Records
One practical challenge in illiquid-investment arbitrations is timing. Public stock losses are often obvious when the market price falls. Illiquid-product problems may surface later—sometimes years later—when statement values change, redemption programs tighten, distributions change, or a liquidity event fails to materialize.
That delay can make older records especially important:
- new account forms,
- notes about risk tolerance and liquidity needs,
- offering documents,
- subscription agreements,
- supervisory approvals,
- annual updates,
- correspondence about redemptions,
- tax forms, and
- later account statements showing estimated value changes.
By the time the dispute matures, the investor may no longer remember the exact sales language, while the firm may rely heavily on signed forms and prospectus disclosures. That is one reason these cases often benefit from counsel who know where to look for objective evidence and how to compare the sales record against the customer’s actual profile.
Public Stocks Usually Provide Faster Feedback; Illiquid Products Often Delay It
A public stock often gives immediate feedback. If the company misses earnings, cuts guidance, or faces litigation, the market may react quickly. Illiquid investments can delay feedback because pricing is not constantly tested in a public market.
That lag can affect arbitration narratives. Investors may say they were reassured by stable statement values or continuing distributions. Firms may respond that the offering documents disclosed illiquidity, risk, and valuation uncertainty. The dispute then becomes less about a single obvious market event and more about whether the product’s structure and disclosures were adequately explained from the start.
Why Attorney Experience In Similar Matters Can Matter More Here
Illiquid-investment arbitration cases often involve a mix of product structure, sales-practice rules, valuation mechanics, and procedural strategy. They are not all the same. A non-traded REIT case may differ materially from a private-placement energy offering, a tenant-in-common structure, or a non-public BDC claim.
That is why some investors look for attorneys with demonstrable experience in highly similar matters—experience visible in court records, arbitration matters, or comparable securities disputes. The goal is not a generic securities lawyer in the abstract, but someone whose background reflects a close match to the issues actually in play: illiquidity, concentration, due diligence, disclosure, and valuation.
The Bottom Line
Illiquid investments create different arbitration issues than publicly traded stocks because the underlying products behave differently. They often lack transparent market pricing, limit investor exits, rely on estimated values, emphasize distributions that can be misunderstood, and raise sharper questions about account fit, due diligence, and sales practices.
That often makes the later dispute more complicated too. Instead of focusing mainly on a price chart, the case may depend on old account forms, subscription documents, supervisory records, valuation methodology, and evidence about how the investment was presented to the investor.
For people dealing with these disputes, a lawyer with relevant experience grounded in objective criteria may help clarify how the facts line up with common arbitration themes in alternative-investment cases.
Visit ReferU.AI to get matched with an attorney who has demonstrable experience in cases like yours — for free.
